🏥Notice of Change to NIH Meeting Schedule
The Department of Health and Human Services announces a change in the meeting of the National Advisory Council for Human Genome Research. Originally scheduled for April 25, 2025, the meeting has been rescheduled to June 18-19, 2025. This meeting will be closed to the public, continuing the council's confidential discussions on genomic research matters.
Learn More🏥Notice of NIH Clinical Center Research Hospital Board Meeting
This notice announces a hybrid meeting of the NIH Clinical Center Research Hospital Board, detailing the agenda, date, and contact information for interested participants. It highlights opportunities for public comment and emphasizes the necessity for special assistance requests, ensuring accessibility for all attendees. The meeting will focus on leadership updates and other business matters relevant to health research.
Learn More💰NIH Notice on Upcoming Closed Meetings for Grant Evaluations
The Department of Health and Human Services has issued a notice about closed meetings held by the NIH regarding the evaluation of grant applications for scientific research. These meetings will discuss critical topics including treatment for substance use disorders and implementation science, aiming to protect sensitive information during the review process.
Learn More🏥Proposed Review for Unaccompanied Children Services Compliance
The Office of Refugee Resettlement (ORR), Administration for Children and Families (ACF), U.S. Department of Health and Human Services is inviting public comment on the proposed collection. The request consists of one form that will allow the Unaccompanied Children (UC) Bureau to provide services to unaccompanied children identified as having a disability.
Learn More🏥NIH Notice of Closed Meetings on Grant Evaluations
The Department of Health and Human Services announces closed meetings of the National Institutes of Health to review grant applications in various scientific fields. These discussions aim to evaluate proposals that may include confidential information, impacting funding opportunities within the health research sector.
Learn More💡NIH Notice on Closed Meetings for Grant Application Evaluation
The Department of Health and Human Services announces closed meetings for the review of grant applications by the National Institutes of Health. These meetings aim to safeguard sensitive discussions around confidential trade secrets and personal information while evaluating various scientific research proposals.
Learn More🏥Change in Meeting Format for Diabetes and Kidney Disease Advisory Council
The National Institute of Diabetes and Digestive and Kidney Diseases has issued a notice of a change in meeting format and time for the Advisory Council. The meeting will now be virtual and partially closed to the public, with new timings set from 10
Learn More❌Cancellation Notice for National Cancer Institute Meeting 2025
The notice informs about the cancellation of the National Cancer Institute Special Emphasis Panel FFRDC Review Meeting scheduled for May 9, 2025. This meeting, previously published in the Federal Register, will not be rescheduled, and further details are provided regarding its official cancellation.
Learn More💰NIH Grants Review Meetings Offer Opportunities for Businesses
The Department of Health and Human Services announces closed meetings for the Center for Scientific Review to evaluate grant applications related to cardiovascular devices and cancer therapeutics. These virtual meetings serve as a crucial platform for funding and advancing innovations in the life sciences sector, with specific focus on competitive review among peers.
Learn More❌Withdrawal of Direct Final Rule on Child Support Services
ACF published in the Federal Register on December 31, 2024, a direct final rule making technical updates throughout Title 45 Code of Federal Regulations (CFR) Chapter III. On February 27, 2025, ACF re- opened the comment period and delayed the effective date until April 28, 2025. The comment period closed March 31, 2025. ACF is withdrawing the direct final rule because the Agency received significant adverse comment.
Learn More